National Institutes of Health
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing June 2, 2027.
Overview
The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate precision probiotic interventions. Specifically, this NOFO solicits R33 applications that will characterize person-specific features affecting probiotic responses to identify subgroups of…